Anti-irritants agents for the treatment of irritant contact dermatitis: Clinical and patent perspective

Recent Patents on Inflammation and Allergy Drug Discovery

Volumn 6, Issue 3, 2012, Pages 169-185

  Zhai, Hongbo ^a   Maibach, Howard I ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Barrier cream (BC); Bioengineering; Irritant contact dermatitis (ICD); Moisturizers; Occupational; Prevention; Treatment

Indexed keywords

ALOE VERA GEL; ALUMINUM HYDROXYCHLORIDE; ANTIPRURITIC AGENT; BARRIER CREAM; BORAGE OIL; CANODERM; CIPAMFYLLINE; CORTICOSTEROID; DERMATOLOGICAL AGENT; DEXPANTHENOL; DICLOFENAC; DIMETICONE; FISH OIL; GLYCOLIC ACID DERIVATIVE; HYDROCORTISONE; LIPO CREAM; LIPO MILK; LIPO OINTMENT; NAPROXEN; PETROLATUM; PIMECROLIMUS; PLACEBO; PROPOLIS; RAPESEED OIL; RETINOIC ACID; SKIN PROTECTIVE AGENT; STRONTIUM; SUNFLOWER OIL; TOLUENE DERIVATIVE; UNCLASSIFIED DRUG; UNINDEXED DRUG; WATER OIL CREAM;

ACNE; ALOE VERA; ARTICLE; BURN; DRUG EFFICACY; ECZEMA; ENZYME INHIBITION; ERYTHEMA; HUMAN; IRRITANT DERMATITIS; PATENT; PRIORITY JOURNAL; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; SKIN FUNCTION; SKIN PROTECTION; SYSTEMATIC REVIEW; TREATMENT RESPONSE; UNITED STATES;

DERMATITIS, IRRITANT; DERMATOLOGIC AGENTS; EVIDENCE-BASED MEDICINE; HUMANS; IRRITANTS; PATENTS AS TOPIC; PRACTICE GUIDELINES AS TOPIC;

EID: 84866719754     PISSN: 1872213X     EISSN: None     Source Type: Journal    
DOI: 10.2174/187221312802652857     Document Type: Article

References (116)

1. th edition, Zhai H, Wilhelm KP, MaibachHI, eds. CRC Press, Boca Raton, FL, 2008; 743-8.
2. Diepgen TL, Coenraads PJ. The epidemiology of occupationalcontact dermatitis. In Handbook of Occupational Dermatology, Kanerva L, Elsner P, Wahlberg JE, Maibach HI, eds. Springer, Berlin,2000; 3-16.
3. Wigger-Alberti W, Elsner P. Contact dermatitis due to irritation. InHandbook of Occupational Dermatology, Kanerva L, Elsner P, Wahlberg JE, Maibach HI, eds. Springer, Berlin, 2000; 99-110.
4. th edition, Zhai H, Wilhelm KP, Maibach HI, eds. CRC Press, Boca Raton, FL, 2008;125-38.
5. Zhai H, Maibach HI. Moisturizers in preventing irritant contactdermatitis: An overview. Contact Dermatitis 1998; 38: 241-4.
6. Zhai H, Maibach HI. Barrier creams and emollients. In IrritantDermatitis, Chew AL, Maibach HI, eds. Springer, Berlin, 2006;479-85.
7. Yokota M, Maibach HI. Moisturizer effect on irritant dermatitis:An overview. Contact Dermatitis 2006; 55: 65-72.
8. Zhai H, Maibach HI. Protection from irritants. Curr Prob Dermatol2007; 34: 47-57.
9. thedition, Zhai H, Wilhelm KP, Maibach HI, eds. CRC Press, BocaRaton, FL, 2008; 299-302.
10. th edition, Zhai H, Wilhelm KP, Maibach HI, eds. CRC Press, Boca Raton, FL, 2008;689-95.
11. Kligman A. Introduction. In Dry Skin and Moisturizers, Lodén M, Maibach HI, eds. CRC Press, Boca Raton, FL, 2000; 3-9.
12. Lodén M. Moisturizers. In Cosmeceuticals. Drugs vs. Cosmetics, Elsner P, Maibach HI, eds. Marcel Dekker, New York, NY, 2000;73-96.
13. Leyden JJ, Rawlings AV, eds. Skin Moisturization. Marcel Dekker, New York, NY, 2002.
14. Thong H-Y, Spoo J, Elsner P, Kleesz P, Maibach HI. Occupationalskin protection-A plea for definitions and a better understanding, Dermatologie in Beruf und Umwelt 2008; 56: 3-6.
15. Federal Register. Skin protectant drug products for over-thecounterhuman use. 1983; 48: 6832.
16. th edition, Zhai H, Wilhelm KP, Maibach HI, eds. CRC Press, Boca Raton, FL, 2008; 279-82.
17. Chew AL, Maibach HI, eds. Irritant Dermatitis. Springer, Berlin,2006.
18. Lupulescu AP, Birmingham DJ. Effect of protective agent againstlipid-solvent-induced damages. Ultrastructural and scanning electronmicroscopical study of human epidermis. Arch Environ Health1976; 31:33-6.
19. Grunewald AM, Gloor M, Gehring W, Kleesz P. Barrier creams. Commercially available barrier creams versus urea-and-glycerolcontaining oil-in-water emulsions. Dermatosen 1995; 43: 69-74.
20. Grunewald AM, Lorenz J, Gloor M, Gehring W, Kleesz P. Lipophilicirritants: Protective value of urea-and of glycerol-containingoil-in-water emulsions. Dermatosen 1996; 44: 81-6.
21. Zhai H, Maibach HI. Effect of barrier creams: Human skin in vivo. Contact Dermatitis 1996; 35: 92-6.
22. Schlüter-Wigger W, Elsner P. Efficacy of 4 commercially availableprotective creams in the repetitive irritation test (RIT). ContactDermatitis 1996; 34: 278-83.
23. Wigger-Alberti W, Elsner P. Petrolatum prevents irritation in ahuman cumulative exposure model in vivo. Dermatol 1997; 194:247-50.
24. Wigger-Alberti W, Rougier A, Richard A, Elsner P. Efficacy ofprotective creams in a modified repeated irritation test. Methodologicalaspects. Acta Dermato Venereologica 1998; 78: 270-3.
25. Wigger-Alberti W, Caduff L, Burg G, Elsner P. Experimentallyinduced chronic irritant contact dermatitis to evaluate the efficacyof protective creams in vivo. J Am Acad Dermatol 1999; 40: 590-6.
26. De Fine Olivarius F, Hansen AB, Karlsmark T, Wulf HC. Waterprotective effect of barrier creams and moisturizing creams: A newin vivo test method. Contact Dermatitis 1996; 35: 219-25.
27. Fartasch M, Schnetz E, Diepgen TL. Characterization of detergentinducedbarrier alterations-effect of barrier cream on irritation. JInvest Dermatol 1998; 3: 121-7.
28. Elsner P, Wigger-Alberti W, Pantini G. Perfluoropolyethers in theprevention of irritant contact dermatitis. Dermatol 1998; 197: 141-5.
29. Zhai H, Willard P, Maibach HI. Evaluating skin protective materialsagainst contact irritants and allergens. An in vivo screening humanmodel. Contact Dermatitis 1998; 38: 155-8.
30. Zhai H, Willard P, Maibach HI. Putative skin protective formulationsin preventing and/or inhibiting experimentally-produced irritantand allergic contact dermatitis. Contact Dermatitis 1999; 41:190-2.
31. Shimizu T, Maibach HI. Squamometry: An evaluation method for abarrier protectant (tannic acid). Contact Dermatitis 1999; 40: 189-91.
32. Patterson SE, Williams JV, Marks JG Jr. Prevention of sodiumlauryl sulfate irritant contact dermatitis by Pro-Q aerosol foam skinprotectant. J Am Acad Dermatol 1999; 40: 783-5.
33. Draelos ZD. Hydrogel barrier/repair creams and contact dermatitis. Am J Contact Dermatitis 2000; 11: 222-5.
34. Zhai H, Brachman F, Pelosi A, Anigbogu A, Ramos MB, TorralbaMC, et al. A bioengineering study on the efficacy of a skin protectantlotion in preventing SLS-induced dermatitis. Skin Res Technol2000; 6: 77-80.
35. Berndt U, Wigger-Alberti W, Gabard B, Elsner P. Efficacy of abarrier cream and its vehicle as protective measures against occupationalirritant contact dermatitis. Contact Dermatitis 2000; 42:77-80.
36. Schnetz E, Diepgen TL, Elsner P, Frosch PJ, Klotz AJ, Kresken J, et al. Multicenter study for the development of an in vivo model toevaluate the influence of topical formulations on irritation. ContactDermatitis 2000; 42: 336-43.
37. McCormick RD, Buchman TL, Maki DG. Double-blind, randomizedtrial of scheduled use of a novel barrier cream and an oilcontaininglotion for protecting the hands of health-care workers. Am J Infect Control 2000; 28: 302-10.
38. Sun Q, Tran M, Smith B, Winefordner JD. In situ evaluation ofbarrier-cream performance on human skin using laser-inducedbreakdown spectroscopy. Contact Dermatitis 2000; 43: 259-63.
39. Perrenoud D, Gallezot D, van Melle G. The efficacy of a protectivecream in a real-world apprentice hairdresser environment. ContactDermatitis 2001; 45: 134-8.
40. De Paépe K, Hachem JP, Vanpee E, Goossens A, Germaux MA, Lachapelle JM, et al. Beneficial effects of a skin tolerance-testedmoisturizing cream on the barrier function in experimentallyelicitedirritant and allergic contact dermatitis. Contact dermatitis2001; 44: 337-43.
41. Zhai H, Schmidt R, Levin C, Klotz A, Maibach HI. Prevention andtherapeutic effects of a model emulsion on glove induced irritationand dry skin in man. Occupational and Environmental Dermatology2002; 4: 134-8.
42. Biro K, Thaci D, Ochsendorf FR, Kaufmann R, Boehncke WH. Efficacy of dexapanthenol in skin protection against irritation: Adouble-blind, placebo-controlled study. Contact Dermatitis 2003;49: 80-4.
43. Diepgen TL, Andersen KE, Schnetz E, Kuss, O, Fartasch, M. Dualcharacteristics of skin care creams evaluated by two in vivo humanexperimental models. J Toxicol Cutan Ocul Toxicol 2003; 22: 157-67.
44. zur Mühlen A, Klotz A, Weimans S, Veeger M, Thörner B, DienerB, et al. Using skin models to assess the effects of a protectioncream on skin barrier function. Skin Pharmacol Physiol 2004; 17:167-75.
45. Teichmann A, Jacobi U, Wailber E, Sterry W, Lademann J. An invivo model to evaluate the efficacy creams on the level of skinpenetration to chemicals. Contact Dermatitis 2006; 54: 5-13.
46. Ortonne JP, Queille-Roussel C. Evaluation of the effect of DardiaLipo Line on skin inflammation induced by surfactants using therepeated open-application test. J Eur Acad Dermatol Venereol2007; 21: (Suppl 2): 19-25.
47. Engel K, Reuter J, Seiler C, Schulte Mönting J, Jakob T, SchemppCM. Anti-inflammatory effect of pimecrolimus in the sodiumlauryl sulphate test. J Eur Acad Dermatol Venereol 2008; 22: 447-50.
48. Hannuksela A, Kinnunen T. Moisturizers prevent irritant dermatitis. Acta Derm Venereol 1992; 72: 42-4.
49. Halkier-Sørensen L, Thestrup-Pedersen K. The efficacy of a moisturizer(Locobase) among cleaners and kitchen assistants duringeveryday exposure to water and detergents. Contact Dermatitis1993; 29: 266-71.
50. Lane AT, Drost SS. Effects of repeated application of emollientcream to premature neonates' skin. Pediatrics 1993; 92: 415-9.
51. Lodén M. Urea-containing moisturizers influence barrier propertiesof normal skin. Arch Dermatol Res 1996; 288: 103-7.
52. Lodén M, Andersson AC. Effect of topically applied lipids onsurfactant-irritated skin. Br J Dermatol 1996; 134: 215-20.
53. El Gammal C, Pagnoni A, Kligman AM, el Gammal S. A model toassess the efficacy of moisturizers-the quantification of soapinducedxerosis by image analysis of adhesive-coated discs (DSquames®). Clin Exp Dermatol 1996; 338-43.
54. Lodén M. Barrier recovery and influence of irritant stimuli in skintreated with a moisturizing cream. Contact Dermatitis 1997; 36:256-60.
55. Ramsing DW, Agner T. Preventive and therapeutic effects of amoisturizer, an experimental study of human skin. Acta DermVenereol 1997; 77: 335-7.
56. Held E, Sveinsdóttir S, Agner T. Effect of long-term use of moisturizeron skin hydration, barrier function and susceptibility to irritants. Acta Derm Venereol 1999; 79: 49-51.
57. Lodén M, Andersson AC, Lindberg M. Improvement in skin barrierfunction in patients with atopic dermatitis after treatment with amoisturizing cream (Canoderm®). Br J Dermatol 1999; 140: 264-7.
58. Held E, Jorgensen LL. The combined use of moisturizers and occlusivegloves: An experimental study. Am J Contact Dermatitis1999; 10: 146-52.
59. Held E, Agner T. Comparison between 2 test models in evaluatingthe effect of a moisturizer on irritated human skin. Contact Dermatitis1999; 40: 261-8.
60. Held E, Agner T. Effect of moisturizers on skin susceptibility toirritants. Acta Derm Venereol 2001; 81: 104-7.
61. Held E, Lund H, Agner T. Effect of different moisturizers on SLSirritatedhuman skin. Contact Dermatitis 2001; 44: 229-34.
62. Buraczewska I, Berne B, Lindberg M, Törmä H, Lodén M. Changes in skin barrier function following long-term treatmentwith moisturizers, a randomized controlled trial. Br J Dermatol2007; 156: 492-8.
63. Alirezai M, Vie K, Humbert P, Valensi P, Cambon L, Dupuy P. Alow-salt medical water reduces irritancy of retinoic acid in facialacne. Eur J Dermatol 2000; 10: 370-2.
64. Wilson TD, Steck WF. A modified HET-CAM assay approach tothe assessment of anti-irritant properties of plant extracts. FoodChem Toxicol 2000; 38: 867-72.
65. Schliemann-Willers S, Wigger-Alberti W, Kleesz P, Grieshaber R, Elsner P. Natural vegetable fats in the prevention of irritant contactdermatitis. Contact Dermatitis 2002; 46: 6-12.
66. Han HJ, Park CW, Lee CH, Yoo CW. A study on anti-irritant effectof Aloe vera gel against the irritation of sodium lauryl sulfate. KoreanJournal of Dermatology 2004; 42: 413-9.
67. Perricone NV, DiNardo JC. Photoprotective and antiinflammatoryeffects of topical glycolic acid. Dermatol Surg 1996; 22: 435-7.
68. Hahn GS. Strontium is a potent and selective inhibitor of sensoryirritation. Dermatol Surg 1999; 25:689-94.
69. Zhai H, Hannon W, Hahn GS, Pelosi A, Harper RA, Maibach HI. Strontium nitrate suppresses chemically-induced sensory irritationin humans. Contact Dermatitis 2000; 42: 98-100.
70. Kucharekova M, Hornix M, Ashikaga T, T'kint S, de Jongh GJ, Schalkwijk J, et al. The effect of the PDE-4 inhibitor (cipamfylline)in two human models of irritant contact dermatitis. Arch DermatolRes 2003; 295: 29-32.
71. van der Valk PG, Maibach HI. Do topical corticosteroids modulateskin irritation in human beings? Assessment by transepidermal waterloss and visual scoring. J Am Acad Dermatol 1989; 21: 519-22.
72. Ramsing DW, Agner T. Efficacy of topical corticosteroids on irritantskin reactions. Contact Dermatitis 1995; 32: 293-7.
73. Levin C, Zhai H, Bashir S, Chew AL, Anigbogu A, Stern R, Maibach H. Efficacy of corticosteroids in acute experimental irritantcontact dermatitis? Skin Res Technol 2001; 7: 214-8.
74. Han A, Maibach HI. Management of acute sunburn. Am J ClinDermatol 2004; 5: 39-47.
75. Andersen F, Hedegaard K, Petersen TK, Bindslev-Jensen C, Fullerton A, Andersen KE. Anti-irritants I: Dose-response in acuteirritation. Contact Dermatitis 2006; 55: 148-54.
76. Andersen F, Hedegaard K, Petersen TK, Bindslev-Jensen C, Fullerton A, Andersen KE. Anti-irritants II: Efficacy against cumulativeirritation. Contact Dermatitis 2006; 55: 155-9.
77. Dinno, R. Topical composition and method for the treatment andprophylaxis of dermal irritations. US20050266094 (2005).
78. Philippe, M., Cohen, C. Inorganic/organic complexes for reducingskin irritation. US6521222 (2003) & US20030143252 (2003).
79. Koh, H. J., Choi, J. K., Jeong, Y.S., Lim, K.M., Moh, J.-H., Bae, J.H., Kim, D. K., Kim, K. M., Lee, C. H., Joo, Y.H., Shin, S. S., Park, Y.-H., Sim, Y. C. A composition containing a thiourea derivativefor preventing or treating pruritic or irritant skin diseases. US20070208080 (2007).
80. Bhatia, K. S., Patel, B. G., Gans, E. H. Triple anti-irritant composition. US20060004071 (2006).
81. DiNardo, J. C., Lewis, J. A. II., Neudecker, B., Diedrich, F., Wieland, E. Method and preparation for reducing irritation and/or inflammatoryreaction in human skin. US20050197407 (2005).
82. Modak, S. M., Shintre, M. S., Caraos, L., Gaonkar, T. Zinc saltcompositions for the prevention of dermal and mucosal irritation. US20040102429 (2004).
83. Modak, S. M., Shintre, M. S., Caraos, L., Gaonkar, T., Geraldo, I. Non-irritating compositions containing zinc salts. US20070020342(2007).
84. Tierney, N., Martin, K., Mitchell, P., Southall, M. Compositionsand methods for mitigating skin irritation. US20070059259 (2007).
85. Lin, S. Q., Weinkauf, R., Santhanam, U., Otts, D.R., Lange, B. A., Tyrrell, D.J., Buhrow, C.S. Cosmetic compositions for preventingskin irritation. US20020119173 (2002).
86. Minerath, B. J. III., Otts, D. R., Huard, L. S., Yrrell, D. J., DiLuccio, R. C., Akin, F.J., Buhrow, C.S., Everhart, D. S., Nelson, B. M., Shanklin, G. L. Substrate composition for sequestration of skin irritants. US6521241 (2003).
87. Minerath, B. J. III., Otts, D. R., Huard, L. S., Tyrrell, D. J., DiLuccio, R. C., Akin, F.J., Buhrow, C.S., Everhart, D. S., Nelson, B. M., Shanklin, G. L. Method for sequestration of skin irritants with substratecompositions. US6551607 (2003).
88. Burnier, V. Electrolyte content w/o emulsions for treating irritated/sensitive skins. US6599512 (2003).
89. Kang, S., Fisher, G. J., Voorhees, J.J. Use of natural EGFR inhibitorsto prevent dermatitis, such as due to cleansers. US040033207(2004).
90. Pereira, A., Joseph, L., Comber, R. Anti-irritants. US091243(2006).
91. Schonrock, U., Steckel, F., Kux, U., Inoue, K. Use of salicin as ananti-irritative active compound in cosmetic and topical dermatologicalpreparations. US5876737 (1999).
92. Morse, T. J. A method of organic and all natural treatment, preventionand relief of diaper dermatitis and other related skin irritations. US20040131704 (2004).
93. Duffy, J. A. Use of ascorbic acid to reduce irritation of topicallyapplied active ingredients. US5516793 (1996).
94. Jutila, K. Preparation protecting skin from mechanical irritation. US6436385 (2002).
95. Knight, E. A., Maes, D. H., Castillo-Bucci, C., Zecchino, J. Nonirritatingcosmetic and pharmaceutical compositions. US6017549(2000).
96. Toma, J. D. R., Karl, C. L. Composition, barrier film, and methodfor preventing contact dermatitis. US5837266 (1998) &US5888520 (1999).
97. Weinkauf, R. L., Habif, S. S., Bartolone, J. B. Trichodesma Lanicumseed extract as an anti-irritant in compositions containing hydroxylacids or retinoids. US5855893 (1999).
98. Wille, J. J. Anti-irritants botanicals. US7399493 (2008).
99. Wille JJ. Novel plant-derived anti-irritants. J Cosmet Sci 2003; 54:106-7.
100. Wille JJ, Kydonieus A, Kalish RS. Inhibition of irritation and contacthypersensitivity by phenoxyacetic acid methyl ester in mice. Skin Pharmacol Appl Skin Physiol 2000; 13: 65-74.
101. Wille, J. J. Prophylactic and therapeutic treatment of skin sensitizationand irritation. US6670395 (2003).
102. Ward, S.J., MacGowan, A., Cork, M.J., Davis, A. Pharmaceuticalcompositions. US20100069338 (2010).
103. Braue, E.H. Jr, Hobson, S.T., Boecker, J.D., Smith, B.M. Activetopical skin protectants containing amines, polyalkenimines and/ orderivatives. US7976832 (2011).
104. Kuljit, S.B., Patel, B.G., Gans, E.H. Triple anti-irritant composition. US7674812 (2010).
105. Muroyama, K., Ohara, T., Hirose, Y., Yamamoto, N., Murosaki, S., Yamamoto, Y. Method of moisturizing skin. US8114658 (2012).
106. Goldemberg RL. Use of anti-irritants in cosmetic formulating. JSoc Cosmetic Chemists 1965; 16: 317-40.
107. Davidson CL. Occupational contact dermatitis of the upper extremity. Occup Med 1994; 9: 59-74.
108. Wigger-Alberti W, Maraffio B, Wernli M, Elsner P. Selfapplicationof a protective cream. Pitfalls of occupational skin protection. Arch Dermatol 1997; 133: 861-4.
109. Wigger-Alberti W, Maraffio B, Wernli M, Elsner P. Trainingworkers at risk for occupational contact dermatitis in the applicationof protective creams: Efficacy of a fluorescence technique. Dermatol 1997; 195: 129-33.
110. Lachapelle JM. Efficacy of protective creams and/or gels. In Preventionof Contact Dermatitis. Current Problem in Dermatology, Elsner P, Lachapelle JM, Wahlberg JE, Maibach HI, eds. Karger, Basel, 1996; 182-92.
111. Frosch PJ, Kurte A, Pilz B. Biophysical techniques for the evaluationof skin protective creams. In Noninvasive Methods for theQuantification of Skin Functions, Frosch PJ Kligman AM, eds. Springer, Berlin, 1993; 214-22.
112. Mathias CGT. Prevention of occupational contact dermatitis. J AmAcad Dermatol 1990; 23: 742-8.
113. Miettinen H, Johansson G, Gobom S, Swanbeck G. Studies onconstituents of moisturizers: Water-binding properties of urea andNaCl in aqueous solutions. Skin Pharmacol Appl Skin Physiol1999; 12: 344-51.
114. Kobayashi R, Takisada M, Suzuki T, Kirimura K, Usami S. Neoagarobioseas a novel moisturizer with whitening effect. Biosci BiotechnolBiochem 1997; 61: 162-3.
115. Jemec GB, Wulf HC. Correlation between the greasiness and theplasticizing effect of moisturizers. Acta Derm Venereol 1999; 79:115-7.
116. Levin C, Maibach HI. Exploration of "alternative" and "natural"drugs in dermatology. Arch Dermatol 2002; 138: 207-11.